Skip to main content
SpringerLink
Log in

Adalimumab/ciclosporin/prednisolone

Exacerbation of impetigo herpetiformis following drug exposure during pregnancy: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Fukushima H, et al. Efficacy and safety of treatment with anti-tumor necrosis factor-alpha drugs for severe impetigo herpetiformis. Journal of Dermatology 48: 207-210, No. 2, Feb 2021. Available from: URL: http://doi.org/10.1111/1346-8138.15635

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Adalimumab/ciclosporin/prednisolone. Reactions Weekly 1868, 19 (2021). https://doi.org/10.1007/s40278-021-00476-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-021-00476-7

Search

Navigation